Home  -  Publications  -  Publications 2016-2017

Publications 2016-2017

Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study.

<< Previous
Back
Next >>
Clikeo Agence Clikeo